Showing results (1-10 of 15,943) with videos related to

Sort By:
Pageof 1,595
European Journal of Medicinal Chemistry|September 22, 2022
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brainYingfang He, Uwe Grether, Marco F Taddio, et al.
European Journal of Medicinal Chemistry|September 23, 2022
Design and optimization of oestrogen receptor PROTACs based on 4-hydroxytamoxifenGuillem Loren, Irene Espuny, Alicia Llorente, et al.
European Journal of Medicinal Chemistry|October 15, 2022
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomasMarilia Barreca, Virginia Spanò, Roberta Rocca, et al.
European Journal of Medicinal Chemistry|October 15, 2022
Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1 to probe its mechanism of functionMilan Dak, Veronika Šlachtová, Marek Šebela, et al.
European Journal of Medicinal Chemistry|October 15, 2022
Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking studyAbdelrahman Hamdi, Walaa M Elhusseiny, Dina I A Othman, et al.
European Journal of Medicinal Chemistry|October 18, 2022
Design, synthesis and anticancer evaluation of novel Se-NSAID hybrid molecules: Identification of a Se-indomethacin analog as a potential therapeutic for breast cancerSandra Ramos-Inza, Ignacio Encío, Asif Raza, et al.
European Journal of Medicinal Chemistry|November 5, 2022
1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogensCui Deng, Heng Yan, Jun Wang, et al.
European Journal of Medicinal Chemistry|November 6, 2022
Recent advances in gout drugsCheng Shi, Ziting Zhou, Xiaowei Chi, et al.
European Journal of Medicinal Chemistry|October 12, 2022
Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastomaCatherine M Mills, Jonathan Turner, Ivett C Piña, et al.
European Journal of Medicinal Chemistry|November 4, 2022
Easy access to α-ketoamides as SARS-CoV-2 and MERS Mpro inhibitors via the PADAM oxidation routeSveva Pelliccia, Carmen Cerchia, Francesca Esposito, et al.
Pageof 1,595